Skip to content

CYTOSORBENTS CORPORATION

CTSO

CIK 0001175151

← back to feed
Revenue (TTM)
$22.92M
+5.9% YoY Q1 May 2026
Net Income (TTM)
−$7.83M
+60.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.12
+65.8% YoY Q1 May 2026
Gross Margin
112.6%
Q1 May 2026
Operating Margin
-58.5%
Q1 May 2026
Net Margin
-34.2%
Q1 May 2026
Free Cash Flow (TTM)
−$13.13M
Q1 May 2026
Cash
$4.81M
Q1 May 2026
Total Debt
$16.96M
Q1 May 2026
Shares Outstanding
62.79M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings